Text Size

The Fate Of Calf Perforators After Endovenous Laser Ablation Of Saphenous Veins

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Ugur Ozkan, MD, Baskent University
ClinicalTrials.gov Identifier:
NCT01458795
First received: October 20, 2011
Last updated: November 2, 2011
Last verified: November 2011
History of Changes
  Purpose

The aim of this study is to evaluate the morphologic and hemodynamic changes in the calf perforators after endovenous laser ablation of saphenous veins.


Condition Intervention Phase
Venous Insufficiency
 Procedure: Endovenous laser ablation
 Phase 4

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Primary Purpose: Treatment
Official Title: The Fate Of Calf Perforators After Endovenous Laser Ablation Of Saphenous Veins

Further study details as provided by Baskent University:

Estimated Enrollment: 60
  Eligibility

Ages Eligible for Study:   20 Years to 80 Years
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • Symptomatic patients who undergo EVLA procedure for saphenous vein insufficiency

Exclusion Criteria:

  • Patients with a history of deep venous thrombosis (DVT)
  • Previous varicose vein surgery or injection sclerotherapy
  • Patients without superficial venous incompetency
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01458795

Locations
Turkey
Baskent University
Adana, Turkey, 01250
Sponsors and Collaborators
Baskent University
  More Information

No publications provided

Responsible Party: Ugur Ozkan, MD, Associate professor of radiology, Baskent University
ClinicalTrials.gov Identifier: NCT01458795     History of Changes
Other Study ID Numbers: bask 012
Study First Received: October 20, 2011
Last Updated: November 2, 2011
Health Authority: Turkey: Ethics Committee

Additional relevant MeSH terms:
Venous Insufficiency
Vascular Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on May 16, 2013